| The House Energy and Commerce Committee, which has been scrutinizing direct-to-consumer drug advertising for Pfizer's Lipitor, along with Vytorin, jointly marketed by Merck & Co. and Schering-Plough Corp., is expanding its probe to more drugs. Committee Chairman John D. Dingell, D-Mich., and Rep. Bart Stupak, D-Mich., wrote Johnson & Johnson to question whether its ads for the cancer drug Procrit are accurate. |




